Clinical Trials in Florida

Showing 3161-3180 of 12,796 trials

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

NCT05913232

The trial will evaluate the safety and efficacy of 3 dose regimens of H-1337 \[0.6% twice daily (b.i.d.), 1.0% b.i.d. and 1.0% once in the morning (q.a.m.), and timolol maleate (0.5%, b.i.d.) in both eyes for 28 days.

Glaucoma Open-Angle PrimaryOcular Hypertension

D. Western Therapeutics Institute, Inc.201 participantsStarted Aug 2023

Glendale, California, United States • Colorado Springs, Colorado, United States • Lakeland, Florida, United States +6 more locations

RECRUITINGPhase 449 miles

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

NCT06765668

The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).

Parkinson Disease

Impax Laboratories, LLC220 participantsStarted Feb 2025

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Aliso Viejo, California, United States +24 more locations

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Find Trials by Condition in Florida

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

ERG Components in Schizophrenia and Bipolar Disorder Type I

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours